At the 2023 Oncology Nursing Society (ONS) Bridge Conference, Dr. Lauren Ghazal, Assistant Professor in the School of Nursing at the University of Rochester Medical School and Oncology Data Advisor Editorial Board member, gave the keynote presentation entitled "Finding Your Why." Afterwards, she sat down to share further insights into the presentation, advice for nurses who are reflecting upon their "why" at different stages of their career, and how asking this question will not only help nurses to build fulfilling careers but to also strengthen nursing sustainability on a larger scale.
At the recent 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, Texas, Susan Rux, Director of Professional Development & Practice Innovation at Temple University, Fox Chase Cancer Center in Philadelphia, Pennsylvania, sat down with Oncology Data Advisor® to talk about nursing civility and its applications for both nursing sustainability and patient care.
Oncology Data Advisor® · Live Podcasts From the 2023 Oncology Nursing Society (ONS) Congress: Part 1 At the 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, Texas, Oncology Data Advisor had the privilege of interviewing many distinguished nursing speakers about their research. This ONS Congress playlist features podcast conversations on topics including the healing power of therapy dogs, the benefits of virtual reality for patients with cancer, strategies for bolste...
Oncology Data Advisor® · ONS Live Podcast: Staying Proficient in Managing Chronic Cancer-Related Pain Tune into this interview live from the 48th Oncology Nursing Society (ONS) Congress, in which Tanya Uritsky, the Opioid Stewardship Coordinator at the Hospital of the University of Pennsylvania, discusses her presentation When Pain Holds a Grudge, Give It a Nudge! Best Practices for Managing Chronic Cancer-Related Pain. Her talk encompasses new and novel interventional thera...
In May of 2022, i3 Health conducted a survey of 230 oncology nurses at the Oncology Nursing Society (ONS) 47th Annual Congress in Anaheim, California, to assess nurses' familiarity and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Genetic evaluation and counseling are ways for patients to better understand their genome and how their DNA might be able to warn them, and even their family, about their risks to certain cancers and diseases. These types of procedure...
i3 Health's study focusing on the effectiveness of a nursing continuing professional development (NCPD)–approved activity to improve clinicians' knowledge of the individualized treatment of patients with non-Hodgkin lymphoma (NHL) has been published as a 47th Annual Oncology Nursing Society (ONS) Congress online abstract. The abstract, authored by Elizabeth Heller, PhD; Keira Smith, BA; Kristin Wright, PharmD; and Sarah Williams, MAT, of i3 Health, and Maria Badillo, MSN, RN, OCN®, CCRP, Researc...
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Nada Lukkahatai of Johns Hopkins School of Nursing gave a presentation about symptom science and her research regarding nonpharmacological interventions to reduce symptom burden. In this interview with Oncology Data Advisor, Dr. Lukkahatai further delves into this research and explains the future of personalized interventions and biomarkers studies for symptom management.
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Bina Parekh, PhD, explained the concept of vicarious trauma and empowered nurses with positive personal growth strategies to deal with challenges, fears, and trauma that stem from dealing with patients with cancer. In this interview with Oncology Data Advisor, Dr. Parekh discusses the concept of vicarious trauma and how nurses, programmed to care for others, are often affected. She shares advice for nurses on how to ad...
At the recent 47th Oncology Nursing Society (ONS) Congress in Anaheim, California, Sherry Adkins, MSN, ANP-C, Advanced Practice Provider Supervisor at MD Anderson Cancer Center, gave a presentation entitled CAR T-Cell Therapy: Care and Considerations Beyond Day 28. She highlighted the fact that although the most common acute toxicities associated with chimeric antigen receptor (CAR) T-cell therapy, including cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndro...
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Mateo Banegas of the University of California, San Diego (UCSD) gave a presentation about the financial toxicity of cancer care, particularly during the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Banegas shares additional advice for members of the cancer care team on how to engage in conversations about financial costs and well-being with their patients.
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Diane Von Ah, Distinguished Professor of Cancer Research at The Ohio State University College of Nursing, gave a presentation about the current state of research regarding cognitive impairment and functional limitation among cancer patients and survivors. In this interview, Dr. Von Ah further expands on her research in this field and explains the role of nurses in improving patients' quality of life both during and after treatment.
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Joscelyn VanDuren, Family Nurse Practitioner at Advanced Oncology Associates in Alaska, gave a presentation about the challenges faced by patients receiving cancer treatment in rural Alaska and her experiences in treating them. Afterwards, she spoke with Oncology Data Advisor to share additional strategies for nurses and nurse practitioners for providing optimal care for their patients residing in rural areas.
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Nicola Stewart, Oncology Nurse Navigator at Methodist Healthcare/Sarah Cannon Cancer Institute, gave a presentation about boosting nursing morale by investing in the individual person and building the team. In this interview with Oncology Data Advisor, she shares additional advice for reigniting the passion as an oncology nurse, including the importance of remembering your "why."
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Grace Smith, Associate Professor at MD Anderson Cancer Center, gave a presentation about the financial toxicity associated with cancer care, particularly in light of the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Smith shares advice for nurses about how they can help prepare, identify, evaluate, and support patients who may experience financial toxicity.
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Leah Scaramuzzo, MSN, RN, MEDSURG-BC, AOCN®, Nursing Director for Oncology Clinical Development at Logan Health, and Alisha Ellis, MSN, RN, OCN®, CHPN, BMTCN®, Staff Nurse and Educator in the Bone Marrow Transplant and Hematology Unit at Franciscan Health, presented an engaging session on how to Capture Your Audience With Innovative Education. Afterwards, they spoke with Oncology Data Advisor to continue their conversation and provide further expertise on how implement creative educational resources into practice, for both patients and providers.
Oncology Data Advisor™ · From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community At the recent 47th Annual Oncology Nursing Society (ONS) Congress, Reverend Sean Parker Dennison, alongside three other professionals, held a panel that explored the topic of improving quality of care for LGBTQIA+ individuals with cancer. In this follow-up interview with Oncology Data Advisor, Reverend Sean expands on their thoughts and provides the valuable perspectiv...
Oncology Data Advisor™ · The Nurse's Role in Oncology Research and Quality Care: Jeannine Brant, PhD, APRN At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Jeannine Brant, PhD, APRN, President of the Oncology Nursing Society (ONS), sat down with Oncology Data Advisor to talk about the exciting research being presented by nurses at ASCO and the critical role of nurses in delivering quality oncology care. This podcast episode was recorded live at t...
From my perch atop the masthead at Oncology Data Advisor, I am awed by the dozens of oncology professionals who give freely of their time and expertise to inform our readership of the latest in their respective areas. Their efforts are what make ODA a premier online resource for all things in this ever-evolving field. My heartfelt thanks go to these wonderful colleagues without whom we would cease to be a publication. In this month's Editor's Letter, I would like to highlight a few of the outsta...
A biosimilar is a biological agent that is very much like another previously FDA-approved biological agent, called the reference drug. Biosimilars and their reference drugs are both made from living organisms, but they may be made in different ways and of slightly different substances. A biosimilar must demonstrate the same safety and efficacy and work in the same way as the reference drug, and it must also be used in the same way, at the same dose, and for the same condition. There are currentl...